Manage Healthy Lipid Levels with Tri-Low
It is summer again and if you are facing any of the seasonal niggles and health concerns Tri-Low would be a good start to take care of your health and fitness. If you need to know more about Tri-Low the full spectrum Indian gooseberry extract and diet supplement from Arjuna Natural Ltd please take a look at this link (link to the earlier blog).
Highly Effective Tri-Low
Tri-Low is a clean powerful, yet harmless cardiac tonic that reduces triglycerides and all pro-atherogenic lipoproteins like LDL cholesterol. Its major advantage over existing cardiac health drugs and dietary supplements is related to the maintenance of COQ10 level. Tri-Low is effective in even the extreme cases of unhealthy lipid profiles featuring unhealthy lipoprotein ratios.
Arjuna Naturals has extracted full spectrum of bioactive ingredients from Indian gooseberry or Amla (Phyllanthus emblica) and this has been seen to be far superior to other products in terms of quality and potency. A published study demonstrates the efficacy and safety of Tri-Low in easing dyslipidemia, a leading risk factor contributing to the development of atherosclerosis. This amla extract has revealed its potential in reducing total cholesterol and triglyceride levels and in bringing about a more favorable balance of lipid ratios.
The ingredients in Tri-Low help achieve lipid balance with no attendant reduction of plasma CoQ10 levels. This is otherwise typically associated with many other lipid-lowering drugs. This supplement also reduced related parameters such as fasting blood glucose, homocysteine levels, and apo-B/apo lipoprotein levels broadening Tri-low's potential in targeting diabetic dyslipidemia.
Tri-Low helps in keeping anti-atherogenic lipoprotein like HDL-cholesterol at an optimum level by enhancing the reverse cholesterol transport (RCT). Tri-Low improves Atherogenic Index of Plasma (AIP), the biochemical predictor of cardiac health. This was supported by a studypublished in the BMC journal of Complementary and Alternative Medicine in January 2019. It showed that major lipids including total cholesterol, triglycerides, LDL cholesterol and VLDL were significantly lower when amla was used. It also showed that anti-atherogenic lipoproteins, such as HDL-cholesterol, were maintained at optimum levels with about 39% reduction in atherogenic index of the plasma (AIP).
Tri-Low provides a full spectrum of bioactive ingredients extracted from wild, fresh, ripe Indian gooseberry fruit (Phyllanthus embolic aka amla). It is standardized with diacylglycerides of ALA - α-Linolenic acid (an omega-3 fatty acid) and polyphenols. The Indian gooseberry, or 'amla', has been used for centuries in many Ayurvedic formulations, known for its all-around health benefits and overall safety. This ingredient is now acknowledged widely as an all-powerful cardiac protector. Tri-Low offers the benefits of this nutraceutical in an improved, more bioactive, and highly concentrated form.
The Processes, the Product and company
While the ingredients themselves are unique,Arjuna's unique and proprietary extraction process enhances Tri-Low’s effectiveness. It preserves ingredient functionality and ensures potency where other amla extracts typically are manufactured from dried amla and makes them different from Tri-Low in quality and activity. Studies have noted the presence of omega-3 fatty acids in amla extract.
The patented product is available in powder form and can be used as such or in combination with other cardiovascular health supplements. This product is made by Curegarden a subsidiary of Arjuna Natural Ltd, India's leading manufacturer and exporter of standardized botanical extracts for the pharmaceutical and nutraceutical industry. The company has been active in the market for about two decades and has found wide acceptance in about 40 countries and markets of the US, Europe, the Middle and Far East.
The company has nearly 50 commercialized patents and has R&D tie ups with international universities from Australia, US and Japan. The GMP and ISO22000 certified company has highly advanced R&D facilities for photochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.
We expect Tri-Low to make a greater market impact in the days to come, especially in the wake of successful lab tests, greater awareness and increasing incidences of life style diseases that are best treated with Tri-Low. I would like to know your views on these points and would be happy to answer your queries.
To receive more articles on organic extracts and health supplements, please register below